SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 161 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $652,000 | -34.5% | 213,766 | -0.6% | 0.00% | 0.0% |
| Q3 2016 | $996,000 | -19.6% | 215,072 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $1,239,000 | -4.8% | 214,071 | -0.4% | 0.00% | 0.0% |
| Q1 2016 | $1,301,000 | -32.8% | 214,972 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $1,937,000 | +27.3% | 212,166 | -21.4% | 0.00% | 0.0% |
| Q3 2015 | $1,522,000 | -21.8% | 269,940 | +53.9% | 0.00% | 0.0% |
| Q2 2015 | $1,946,000 | -33.7% | 175,429 | -6.3% | 0.00% | -33.3% |
| Q1 2015 | $2,935,000 | -19.0% | 187,172 | -21.4% | 0.00% | -25.0% |
| Q4 2014 | $3,623,000 | +17.7% | 238,226 | -16.5% | 0.00% | +33.3% |
| Q3 2014 | $3,078,000 | +193.1% | 285,377 | +314.9% | 0.00% | +200.0% |
| Q2 2014 | $1,050,000 | -24.8% | 68,776 | -11.0% | 0.00% | 0.0% |
| Q1 2014 | $1,397,000 | +7.0% | 77,250 | -17.8% | 0.00% | 0.0% |
| Q4 2013 | $1,305,000 | +93.3% | 93,946 | +45.9% | 0.00% | 0.0% |
| Q3 2013 | $675,000 | +164.7% | 64,370 | +97.1% | 0.00% | – |
| Q2 2013 | $255,000 | – | 32,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |